Acute radiation syndrome

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:454831T66
Who is this for?
Show terms as
1FDA treatments2Active trials49Specialists8Treatment centers1Financial resources

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

Acute radiation syndrome (ARS), also known as radiation sickness or radiation toxicity, is a serious illness that happens when the entire body (or a large part of it) receives a high dose of radiation in a short period of time, usually within minutes. This is not a genetic disease — it is caused by external exposure to ionizing radiation, such as from a nuclear accident, nuclear weapon detonation, or a serious industrial radiation incident. ARS affects the body by damaging rapidly dividing cells, especially in the bone marrow, the lining of the gut, and the nervous system. The severity depends on the radiation dose received. At lower but still dangerous doses, the bone marrow is most affected, leading to a drop in blood cells that causes infections, bleeding, and anemia. At higher doses, the intestinal lining breaks down, causing severe diarrhea, dehydration, and infection. At very high doses, the brain and nervous system are damaged, which can be rapidly fatal. The illness typically unfolds in phases. First, there is a prodromal phase with nausea, vomiting, and fatigue that may appear within hours. This can be followed by a latent period where the person feels temporarily better, before the main illness sets in. Treatment is largely supportive and depends on the dose received. It may include blood transfusions, antibiotics, growth factors to stimulate bone marrow recovery, and in some cases, bone marrow transplantation. Medications like Neupogen (filgrastim), Neulasta (pegfilgrastim), and Leukine (sargramostim) have been approved by the FDA to treat the blood cell effects of ARS.

Also known as:

Key symptoms:

Nausea and vomitingDiarrhea (sometimes bloody)Severe fatigue and weaknessLoss of appetiteFever and infectionsUnusual bleeding or bruisingHair lossSkin burns or rednessHeadacheDizziness or disorientationLow blood cell countsDehydrationMouth soresSeizures (in very high dose exposure)Loss of consciousness (in very high dose exposure)

Clinical phenotype terms (24)— hover any for plain English
TelangiectasiaHP:0001009Decreased total granulocyte countHP:0001913Interstitial pneumonitisHP:0006515
Inheritance

Sporadic

Usually appears on its own, not inherited from a parent

Age of Onset

Variable

Can begin at different ages, from infancy through adulthood

Orphanet ↗NORD ↗

FDA & Trial Timeline

6 events
Mar 2025A MAajor RAdiation-based PCI Study in STEMI and NSTEMI

Centre Cardiologique du Nord

TrialNOT YET RECRUITING
May 2024The Clinical Study of Post-operative Proton Radiotherapy for Thymus Tumor

Jian Chen — PHASE2

TrialRECRUITING
Jan 2023Deep-sea Fish Oil for Prevention of Acute Radiation-induced Esophagitis

First Affiliated Hospital of Chengdu Medical College — PHASE2

TrialRECRUITING
Apr 2021A Modified Dose of Rabbit Anti-thymocyte Globulin (rATG) in Children and Adults Receiving Treatment to Help Prepare Their Bodies for a Bone Marrow Transplant

Memorial Sloan Kettering Cancer Center — PHASE2

TrialACTIVE NOT RECRUITING
Feb 2020TBI Using IMRT (VMAT or Tomotherapy) for the Prevention of Pul Toxicities in Patients Undergoing Donor SCT

City of Hope Medical Center — PHASE1

TrialACTIVE NOT RECRUITING
Jan 2020Retrospective Analysis of Chest X-ray Severity Scoring System of COVID-19 Pneumonia

Osijek University Hospital

TrialRECRUITING

Data sourced from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.

Treatments

1 available

Neulasta

Pegfilgrastim· Amgen, Inc.

Increase survival in patients acutely exposed to myelosuppressive doses of radiation (Hematopoietic Subsyndrome of Acute Radiation Syndrome)

Clinical Trials

2 recruitingView all trials with filters →
Phase 22 trials
Deep-sea Fish Oil for Prevention of Acute Radiation-induced Esophagitis
Phase 2
Actively Recruiting
· Sites: Chengdu · Age: 1870 yrs
The Clinical Study of Post-operative Proton Radiotherapy for Thymus Tumor
Phase 2
Actively Recruiting
PI: Jingfang Mao, PHD (Shanghai Proton and Heavy Ion Center) · Sites: Shanghai, Shanghai Municipality · Age: 1870 yrs

Specialists

Showing 25 of 49View all specialists →
NM
Nicholas Siebers, MD
MADISON, WI
Specialist
PI on 2 active trials
JM
Jane Liesveld, MD
ROCHESTER, NY
Specialist
PI on 1 active trial
MP
Michael D Kaytor, Ph.D.
Specialist
PI on 1 active trial
SM
Sumithira Vasu, MD
COLUMBUS, OH
Specialist
PI on 3 active trials
YM
Yuhchyau Chen, MD,PhD
ROCHESTER, NY
Specialist
PI on 1 active trial
CM
Chun Chao Huang, MD
Specialist
PI on 1 active trial
RM
Robert Lowsky, MD
STANFORD, CA
Specialist
PI on 2 active trials
FM
Filippo Milano
SEATTLE, WA
Specialist
PI on 7 active trials2 Acute radiation syndrome publications
DM
Damiano Rondelli, MD
CHICAGO, IL
Specialist
PI on 4 active trials
SM
Steven Devine, MD
LA CROSSE, WI
Specialist
PI on 4 active trials
MM
Monzr M Al Malki
Specialist
PI on 4 active trials1 Acute radiation syndrome publication
DP
Daniel J. DeAngelo, MD, PhD
HIAWATHA, KS
Specialist
PI on 3 active trials
SD
Savita V Dandapani
DUARTE, CA
Specialist
PI on 2 active trials
JW
Jeffrey Y Wong
Specialist
PI on 6 active trials110 Acute radiation syndrome publications
MR
Maureen Ross
Buffalo, New York
Specialist

Rare Disease Specialist

PI on 1 active trial41 Acute radiation syndrome publications

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

Financial Resources

1 resources
Neulasta(Pegfilgrastim)Amgen, Inc.

Travel Grants

No travel grants are currently matched to Acute radiation syndrome.

Search all travel grants →NORD Financial Assistance ↗

Community

Open Acute radiation syndromeForum →

No community posts yet. Be the first to share your experience with Acute radiation syndrome.

Start the conversation →

Latest news about Acute radiation syndrome

Disease timeline:

New recruiting trial: Deep-sea Fish Oil for Prevention of Acute Radiation-induced Esophagitis

A new clinical trial is recruiting patients for Acute radiation syndrome

New recruiting trial: Retrospective Analysis of Chest X-ray Severity Scoring System of COVID-19 Pneumonia

A new clinical trial is recruiting patients for Acute radiation syndrome

New recruiting trial: Intensity Modulated Total Marrow Irradiation in Fully Human Leukocyte Antigen (HLA)-Matched and Partially-HLA Mismatched Allogeneic Transplantation Patients With High-Risk Acute Myeloid Leukemia (AML), Chronic Myeloid Leukemia (CML), and Myelodysplastic Syndrome (MDS)

A new clinical trial is recruiting patients for Acute radiation syndrome

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Questions for your doctor

Bring these to your next appointment

  • Q1.What radiation dose am I estimated to have received, and what does that mean for my health?,What phase of acute radiation syndrome am I in, and what should I expect next?,What treatments will I receive, and how will they help my recovery?,How long will I need to stay in the hospital, and what will my recovery look like?,What are the long-term health risks I should be aware of, including cancer risk?,Should my family members or others who were nearby also be evaluated?,What psychological support services are available for me and my family?

Common questions about Acute radiation syndrome

What is Acute radiation syndrome?

Acute radiation syndrome (ARS), also known as radiation sickness or radiation toxicity, is a serious illness that happens when the entire body (or a large part of it) receives a high dose of radiation in a short period of time, usually within minutes. This is not a genetic disease — it is caused by external exposure to ionizing radiation, such as from a nuclear accident, nuclear weapon detonation, or a serious industrial radiation incident. ARS affects the body by damaging rapidly dividing cells, especially in the bone marrow, the lining of the gut, and the nervous system. The severity depend

How is Acute radiation syndrome inherited?

Acute radiation syndrome follows a sporadic inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.

Are there clinical trials for Acute radiation syndrome?

Yes — 2 recruiting clinical trials are currently listed for Acute radiation syndrome on UniteRare. See the clinical trials section on this page for phase, sponsor, and site details sourced from ClinicalTrials.gov.

Which specialists treat Acute radiation syndrome?

25 specialists and care centers treating Acute radiation syndrome are listed on UniteRare, sourced from ClinicalTrials.gov principal investigators, published research, and the NPPES NPI registry.

What treatment and support options exist for Acute radiation syndrome?

1 patient support program are currently tracked on UniteRare for Acute radiation syndrome. See the treatments and support programs sections for copay assistance, eligibility, and contact details.